olivlawolivlaw

olivLaw · US equity research

Kimberly-Clark Corporation KMB

Converted Paper & Paperboard Prods (No Contaners/Boxes) · SIC 2670 · Vertical: Paper and allied products (SIC 267x)

104.46USD−3.50% · 1 dayClose 03 Nov 2026

Kimberly-Clark (KMB) is a global maker of essential products from fibers and nonwovens, with brands such as Huggies, Kleenex and Scott sold in more than 175 countries and territories. The company is preparing to acquire Kenvue, for which about 6.7 billion USD is expected to be paid, and completed a joint venture with Suzano for its IFP operations, valued at about 1.7 billion USD. The 2026 outlook shows organic sales growth slightly below its categories, due to China disruptions.

At the close of 03 Nov 2026, Kimberly-Clark Corporation (KMB) stock was 104.46 USD (−3.50% on the day), with market capitalisation 34.7 bn USD, P/E 17.8 on diluted EPS of 5.88 USD over the last 12 months, dividend yield 4.86%, beta 0.07, 52-week range 93.05–114.74 USD. Latest reported quarter (Q2 2026): revenue of 4.2 bn USD (+0.6% YoY), net income of 345.0 m USD (−32.2% YoY), diluted EPS 1.04 USD.

Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.

Market cap
34.7 bn USD
shares as of 28 Jul 2026
P/E (TTM)
17.8
Diluted EPS TTM 5.88 · TTM to 30 Jun 2026
E/P (TTM)
5.63%
TTM to 30 Jun 2026
Dividend yield
4.86%
DPS 12m 5.08
Beta (2y)
0.07
Volatility (1y) 29%
52-week range
93.05114.74

Price history

Loading chart…

Technical reading

RSI (14)
49.0
neutral
Bollinger (20, 2)
95.08 – 114.78
in the lower half of the band · %B 0.48 · band width 18.8%
SMA 50 / 200
102.66 / 103.06
mixed trend
MACD (12, 26, 9)
1.99 / 2.02
MACD below signal

Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).

Performance

CompanyS&P 500vs S&P 500Vertical median
1 month+10.7%−2.0%+12.7 pp—
3 months−6.4%−2.2%−4.2 pp—
6 months+7.5%+4.3%+3.2 pp—
Year to date+3.5%+10.6%−7.0 pp—
1 year+2.1%+10.5%−8.3 pp−32.0%
3 years−12.5%+73.7%−86.2 pp−18.0%
5 years−20.4%+61.7%−82.1 pp—
Max drawdown (1y)
−17.8%
07 Jul 2026 → 01 Oct 2026
Max drawdown (5y)
−37.3%
04 Sept 2024 → 07 Apr 2026
Compound annual growth (5y)
−4.5%
S&P 500 +10.1%

Price returns, dividends excluded.

Quarterly results

Latest quarter: Q2 2026 · 30 Jun 2026

Revenue
4.2 bn USD
+0.6% YoY
Net income
345.0 m USD
−32.2% YoY
Diluted EPS
1.04
−32.0% YoY
net / operating
8.2% / 15.1%

Quarterly margins

Quarterly statements · USD

Fiscal yearQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Revenue4.1 bn4.1 bn4.1 bn4.2 bn4.2 bn4.1 bn4.2 bn4.2 bn
Cost of revenue2.6 bn2.7 bn2.5 bn2.7 bn2.7 bn2.6 bn2.6 bn2.6 bn
Gross profit1.6 bn1.4 bn1.5 bn1.5 bn1.5 bn1.5 bn1.5 bn1.6 bn
Operating income1.0 bn420.0 m631.0 m592.0 m621.0 m507.0 m753.0 m633.0 m
Depreciation & amortisation191.0 m ≈217.0 m218.0 m222.0 m ≈176.0 m ≈189.0 m193.0 m167.0 m ≈
Interest expense67.0 m64.0 m64.0 m67.0 m65.0 m60.0 m58.0 m53.0 m
Pre-tax income962.0 m861.0 m557.0 m513.0 m546.0 m436.0 m685.0 m572.0 m
Income tax187.0 m47.0 m131.0 m116.0 m248.0 m104.0 m164.0 m217.0 m
Net income907.0 m447.0 m567.0 m509.0 m446.0 m499.0 m665.0 m345.0 m
Diluted EPS2.691.341.701.531.341.502.001.04
Operating cash flow958.0 m ≈817.0 m327.0 m770.0 m ≈708.0 m ≈972.0 m745.0 m908.0 m ≈
Capex160.0 m ≈209.0 m204.0 m197.0 m ≈340.0 m ≈397.0 m424.0 m352.0 m ≈
Dividends paid411.0 m ≈408.0 m405.0 m419.0 m ≈418.0 m ≈418.0 m418.0 m425.0 m ≈
Share repurchases596.0 m ≈248.0 m61.0 m59.0 m ≈20.0 m ≈1.0 m00 ≈

≈ derived quarter (cumulative difference / share-days average)

E/P over time

E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.

Today's P/E sits at the 9 percentile of its own 43-quarter history (min 15.1, median 21.7, max 46.1; quarters with earnings only).

Fiscal years

Fiscal year20182019202020212022202320242025
Revenue18.5 bn18.5 bn19.1 bn19.4 bn20.2 bn17.1 bn16.8 bn16.4 bn
Revenue YoY+0.8%−0.2%+3.7%+1.6%+3.8%−15.0%−2.0%−2.1%
Net income1.4 bn2.2 bn2.4 bn1.8 bn1.9 bn1.8 bn2.5 bn2.0 bn
Net income YoY−38.1%+53.0%+9.0%−22.9%+6.6%−8.8%+44.3%−20.6%
Diluted EPS4.036.246.875.355.725.217.556.07
Diluted EPS YoY−37.0%+54.8%+10.1%−22.1%+6.9%−8.9%+44.9%−19.6%
net %7.6%11.7%12.3%9.3%9.6%10.3%15.1%12.3%
Free cash flow2.1 bn1.5 bn2.5 bn1.7 bn1.9 bn2.8 bn2.5 bn1.6 bn

Reported results vs expectations

Loading…

Balance sheet & financial health

Fiscal year 2025 · 31 Dec 2025

Cash
688.0 m USD
Financial debt
694.0 m USD
Net debt
6.0 m USD
Equity
1.6 bn USD
Total assets
17.1 bn USD
Debt / equity
0.43x
Current ratio
0.75x
ROE
155.2%
ROA
12.0%
FCF margin
10.0%

Financial statements (source on every figure)

Revenue and net income (USD)

Margins

Income statement · USD

Revenue
2023
17.1 bn
2024
16.8 bn
2025
16.4 bn

SEC (XBRL)· 12 Feb 2026verified

Cost of revenue
2023
10.9 bn
2024
10.5 bn
2025
10.5 bn

SEC (XBRL)· 12 Feb 2026verified

Gross profit
2023
6.3 bn
2024
6.3 bn
2025
5.9 bn

SEC (XBRL)· 12 Feb 2026verified

Research & development
2023
303.0 m
2024
328.0 m
2025
326.0 m

SEC (XBRL)· 12 Feb 2026verified

Operating income
2023
1.9 bn
2024
2.7 bn
2025
2.4 bn

SEC (XBRL)· 12 Feb 2026verified

Depreciation & amortisation
2023
753.0 m
2024
781.0 m
2025
805.0 m

SEC (XBRL)· 12 Feb 2026verified

EBITDA
2023
2.7 bn ≈
2024
3.5 bn ≈
2025
3.2 bn ≈

SEC (XBRL)· 12 Feb 2026derived

Interest expense
2023
293.0 m
2024
270.0 m
2025
256.0 m

SEC (XBRL)· 12 Feb 2026verified

Pre-tax income
2023
2.0 bn
2024
2.9 bn
2025
2.1 bn

SEC (XBRL)· 12 Feb 2026verified

Income tax
2023
343.0 m
2024
442.0 m
2025
599.0 m

SEC (XBRL)· 12 Feb 2026verified

Net income
2023
1.8 bn
2024
2.5 bn
2025
2.0 bn

SEC (XBRL)· 12 Feb 2026verified

Diluted EPS
2023
5.21
2024
7.55
2025
6.07

SEC (XBRL)· 12 Feb 2026verified

Weighted average diluted shares
2023
338.8 m
2024
337.0 m
2025
333.2 m

SEC (XBRL)· 12 Feb 2026verified

Dividend per share
2023
4.72
2024
4.88
2025
5.04

SEC (XBRL)· 12 Feb 2026verified

Balance sheet · USD

Cash
2023
1.1 bn
2024
1.0 bn
2025
688.0 m

SEC (XBRL)· 12 Feb 2026verified

Receivables
2023
2.1 bn
2024
1.7 bn
2025
1.9 bn

SEC (XBRL)· 12 Feb 2026verified

Inventories
2023
2.0 bn
2024
1.5 bn
2025
1.5 bn

SEC (XBRL)· 12 Feb 2026verified

Current assets
2023
5.7 bn
2024
5.6 bn
2025
5.3 bn

SEC (XBRL)· 12 Feb 2026verified

Property, plant & equipment, net
2023
7.9 bn
2024
6.3 bn
2025
6.8 bn

SEC (XBRL)· 12 Feb 2026verified

Goodwill
2023
1.9 bn
2024
1.8 bn
2025
1.8 bn

SEC (XBRL)· 12 Feb 2026verified

Intangibles (excl. goodwill)
2023
197.0 m
2024
80.0 m
2025
77.0 m

SEC (XBRL)· 12 Feb 2026verified

Total assets
2023
17.3 bn
2024
16.5 bn
2025
17.1 bn

SEC (XBRL)· 12 Feb 2026verified

Accounts payable
2023
3.7 bn
2024
3.3 bn
2025
3.4 bn

SEC (XBRL)· 12 Feb 2026verified

Short-term debt
2023
567.0 m
2024
564.0 m
2025
694.0 m

SEC (XBRL)· 12 Feb 2026verified

Current liabilities
2023
6.9 bn
2024
7.0 bn
2025
7.1 bn

SEC (XBRL)· 12 Feb 2026verified

Equity
2023
1.1 bn
2024
975.0 m
2025
1.6 bn

SEC (XBRL)· 12 Feb 2026verified

Cash flow · USD

Operating cash flow
2023
3.5 bn
2024
3.2 bn
2025
2.8 bn

SEC (XBRL)· 12 Feb 2026verified

Capex
2023
766.0 m
2024
721.0 m
2025
1.1 bn

SEC (XBRL)· 12 Feb 2026verified

Free cash flow
2023
2.8 bn ≈
2024
2.5 bn ≈
2025
1.6 bn ≈

SEC (XBRL)· 12 Feb 2026derived

Investing cash flow
2023
-418.0 m
2024
-100.0 m
2025
-951.0 m

SEC (XBRL)· 12 Feb 2026verified

Financing cash flow
2023
-2.4 bn
2024
-3.2 bn
2025
-2.2 bn

SEC (XBRL)· 12 Feb 2026verified

Dividends paid
2023
1.6 bn
2024
1.6 bn
2025
1.7 bn

SEC (XBRL)· 12 Feb 2026verified

Share repurchases
2023
225.0 m
2024
1.0 bn
2025
141.0 m

SEC (XBRL)· 12 Feb 2026verified

Computed indicators

Growth

Revenue growth (YoY)
-2.1%
computed by olivLawFY 2025
Revenue CAGR 3Y
-6.6%
computed by olivLawFY 2022 → FY 2025
Revenue CAGR 5Y
-3.0%
computed by olivLawFY 2020 → FY 2025
EBIT growth (YoY)
-12.9%
computed by olivLawFY 2025
Net income growth (YoY)
-20.6%
computed by olivLawFY 2025
Net income CAGR 3Y
1.5%
computed by olivLawFY 2022 → FY 2025
Net income CAGR 5Y
-3.0%
computed by olivLawFY 2020 → FY 2025
EPS growth (YoY)
-19.6%
computed by olivLawFY 2025
EPS CAGR 3Y
2.0%
computed by olivLawFY 2022 → FY 2025
EPS CAGR 5Y
-2.4%
computed by olivLawFY 2020 → FY 2025
FCF growth (YoY)
-34.8%
computed by olivLawFY 2025

Profitability

Gross margin
36.8%
computed by olivLawTTM to 30 Jun 2026
EBITDA margin
19.5%
computed by olivLawTTM to 30 Jun 2026
EBIT margin
15.2%
computed by olivLawTTM to 30 Jun 2026
Net margin
11.8%
computed by olivLawTTM to 30 Jun 2026
FCF margin
11.0%
computed by olivLawTTM to 30 Jun 2026

Returns

ROE
129.4%
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
ROA
11.1%
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
ROIC
135.2%
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
ROCE
21.7%
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
Payout ratio (EPS)
86.4%
computed by olivLawTTM to 30 Jun 2026
Payout ratio (FCF)
92.3%
computed by olivLawTTM to 30 Jun 2026

Balance sheet

Net debt
-913.0 m USD
computed by olivLawbalance sheet at 30 Jun 2026
Net debt / EBITDA
-0.3x
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
Debt / equity
0.0x
computed by olivLawbalance sheet at 30 Jun 2026
Interest coverage
10.7x
computed by olivLawTTM to 30 Jun 2026

Liquidity

Current ratio
0.9x
computed by olivLawbalance sheet at 30 Jun 2026
Quick ratio
0.7x
computed by olivLawbalance sheet at 30 Jun 2026
Cash ratio
0.1x
computed by olivLawbalance sheet at 30 Jun 2026

Cash

Operating cash flow
3.3 bn USD
computed by olivLawTTM to 30 Jun 2026
Capital expenditure
1.5 bn USD
computed by olivLawTTM to 30 Jun 2026
Free cash flow
1.8 bn USD
computed by olivLawTTM to 30 Jun 2026
FCF conversion
93.1%
computed by olivLawTTM to 30 Jun 2026
Cash conversion
102.9%
computed by olivLawTTM to 30 Jun 2026

Efficiency

Days sales outstanding
43 days
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
Days inventory outstanding
54 days
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
Days payables outstanding
115 days
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
Cash conversion cycle
-19 days
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026

Market and valuation

Market capitalisation
34.7 bn USD
computed by olivLawbalance sheet at 30 Jun 2026
Enterprise value
33.8 bn USD
computed by olivLawbalance sheet at 30 Jun 2026
Market cap / net income TTM
17.8x
computed by olivLawTTM to 30 Jun 2026
P/E (TTM)
17.8x
computed by olivLawTTM to 30 Jun 2026
Earnings yield
5.6%
computed by olivLawTTM to 30 Jun 2026
P/B
19.9x
computed by olivLawbalance sheet at 30 Jun 2026
P/S
2.1x
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
EV/EBITDA
10.4x
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
EV/EBIT
13.5x
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
EV/Sales
2.0x
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
P/FCF
19.1x
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
FCF yield
5.2%
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
Dividend yield
4.9%
computed by olivLawTTM to 30 Jun 2026
Shareholder yield (distributions)
4.9%
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026

1 indicators that do not apply to the sector.

Valuation

olivLaw classification

Unattractive profile

Score: 62 / 100

A scoring methodology on indicators and valuation, not investment advice.

(margin_of_safety <= -0.25 & agreement in ['high', 'medium'])

Closing price

104.46 USD

03 Nov 2026Source: olivLaw, closing series

Market cap: 34.7 bn USD

Key indicators

Market capitalisation
34.7 bn USD
computed by olivLawbalance sheet at 30 Jun 2026
P/E (TTM)
17.8x
computed by olivLawTTM to 30 Jun 2026
P/B
19.9x
computed by olivLawbalance sheet at 30 Jun 2026
EV/EBITDA
10.4x
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
ROE
129.4%
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
Net margin
11.8%
computed by olivLawTTM to 30 Jun 2026
Revenue growth (YoY)
-2.1%
computed by olivLawFY 2025
Dividend yield
4.9%
computed by olivLawTTM to 30 Jun 2026

Coverage and freshness

33/37 reporting lines present
Latest full fiscal year: 2025
Latest reported period: 30 Jun 2026
Latest balance sheet date: 30 Jun 2026
Share count (cover of the latest filing), as of: 28 Jul 2026
Source: SEC (XBRL)published 04 Aug 2026
verified 2846derived 237

Score by group

  • Balance sheet82
  • Growth7
  • Quality97
  • Returns58
  • Valuation53

Estimated value range

Low
65.88
USD per share
Mid
76.98
USD per share
High
93.26
USD per share
Price: 104.46 USD
The price is above the range
Potential to the central value: -26.3% (value / price − 1)
Margin of safety: -35.7% (1 − price / value)
Agreement between methods: high · 2 methods used · 2 independent bases

The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 65.52 – 97.45 USD.

Valuation assumptions are editorial choices, not measured; beta is not measured.

Method ranges (USD per share)

— — Mid · ▏ Price

Valuation methods

  • DCF (discounted cash flow)65.52 – 97.45 (Mid 77.99)
    WACC 9.3% · starting FCFF 2.0 bn USD · terminal value share of EV 72%
    The WACC × g sensitivity gives the method's bounds; these are not probabilities.
    Reverse DCF: starting growth implied by the price (fading linearly to terminal growth, everything else fixed): 8.1%
  • Peers: EV/EBITDAunavailable · not enough peers
  • Peers: P/Eunavailable · not enough peers
  • Dividend discount (DDM)66.23 – 89.07 (Mid 75.97)
Multiple comparisons use the SIC vertical: Paper and allied products (SIC 267x)

Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.

Assumptions (illustrative, editorial)

Risk-free rate
4.3%
Equity risk premium
5.0%
Beta (default)
1.00
Cost of equity
9.3%
Terminal growth
2.5%

Factor scorecard

Unattractive profile · Score 62/100

FactorValueScoreWeight used
ROIC · Quality135.2%100 (on a fixed band)10%
Net margin · Quality11.8%100 (vs peers)6%
FCF conversion · Quality93.1%90 (on a fixed band)6%
Revenue CAGR 3Y · Growth-6.6%0 (on a fixed band)8%
EPS CAGR 3Y · Growth2.0%13 (on a fixed band)8%
Net debt / EBITDA · Balance sheet-0.3x100 (on a fixed band)10%
Interest coverage · Balance sheet10.7x100 (on a fixed band)6%
Current ratio · Balance sheet0.9x9 (on a fixed band)4%
P/E (TTM) · Valuation17.8x56 (on a fixed band)10%
EV/EBITDA · Valuation10.4x41 (on a fixed band)10%
FCF yield · Valuation5.2%65 (on a fixed band)8%
Shareholder yield (distributions) · Returns4.9%70 (on a fixed band)6%
Payout ratio (FCF) · Returns92.3%40 (on a fixed band)4%

Score groups

  • Balance sheet82/100 · 3/3 factors with a value
  • Growth7/100 · 2/2 factors with a value
  • Quality97/100 · 3/3 factors with a value
  • Returns58/100 · 2/2 factors with a value
  • Valuation53/100 · 3/3 factors with a value

Memo

KIMBERLY-CLARK CORPORATION (KMB). Latest full fiscal year: 2025; data up to 2026-06-30.

Figures computed from the financial statements: revenue 16.4 bn USD in 2025; YoY growth -2.1%; net margin 11.8%; ROE 129.4%; net debt/EBITDA -0.3x.

The estimated value range is 65.88–93.26 USD per share (median of 2 methods, agreement: high); assumptions are illustrative. Against the central value of 76.98 USD, the price of 104.46 USD leaves a potential of -26.3% (value / price − 1) and a margin of safety of -35.7% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.

olivLaw score 62/100, methodological classification: unattractive profile (score, margin of safety and method agreement together; not a judgement of the right price). Not investment advice.

Text generated deterministically from the figures shown; no language model. Not investment advice.

What supports the thesis

  • ROIC: 135.2%
  • Net margin: 11.8%
  • FCF conversion: 93.1%
  • Net debt / EBITDA: -0.3x
  • Interest coverage: 10.7x

What contradicts it

  • Revenue CAGR 3Y: -6.6%
  • EPS CAGR 3Y: 2.0%
  • Current ratio: 0.9x
  • The price is above the estimated value range

Versus the vertical median

Paper and allied products (SIC 267x) · same industry group (3-digit SIC) · compared with 5 companies

The size band was not applied: too few companies would have remained; the vertical includes much smaller or larger companies.

Multiples and returns vs the median

P/E
17.8x
vertical median —
EV/EBITDA
10.4x
vertical median —
P/S
2.1x
vertical median 1.4x
above median (+49.5%)
P/B
19.9x
vertical median 2.3x
above median (+748.9%)
ROE
129.4%
vertical median -6.6%
above median
Net margin
11.8%
vertical median -8.3%
above median
EBIT margin
15.2%
vertical median -12.6%
above median
Revenue YoY
-2.1%
vertical median 0.7%
below median (−402.8%)
Net debt/EBITDA
-0.3x
vertical median —
Dividend yield
4.9%
vertical median —

Price rebased to 100 (monthly, 5 years)

Companies in the vertical

Market capP/EROENet marginRevenue YoY1A / 3A
KMBKimberly-Clark Corporation34.7 bn17.8129.4%11.8%−2.1%+2% / −13%
AVYAvery Dennison Corporation14.5 bn20.830.8%7.6%+1.1%+12% / −1%
REYNReynolds Consumer Products Inc.5.3 bn16.115.0%8.7%+0.7%+1% / −4%
PACKRanpak Holdings Corp.288.2 m—-6.6%-8.3%+7.1%−32% / −18%
DSYBig Tree Cloud Holdings Limited284.1 m—-232.8%-551.3%−49.3%−64% / −98%
ITPIt Tech Packaging, Inc.2.1 m—-6.9%-13.9%−12.4%−45% / −57%

1- and 3-year price returns: for KMB from daily closes (the same as the performance table), for the other companies from month-end closes.

olivLaw engine forecast

The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.

Valuation scenarios (editable assumptions)

Illustrative scenarios

Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.

Bear
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Base
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Bull
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Nothing is saved.

Estimated price (USD)

Estimated priceBearBaseBull
1 years
55.83
Total return -43% · Per year -43%
99.21
Total return -0% · Per year -0%
150.12
Total return 49% · Per year 49%
3 years
44.33
Total return -48% · Per year -20%
89.54
Total return -1% · Per year -0%
150.12
Total return 60% · Per year 17%
5 years
35.20
Total return -52% · Per year -14%
80.81
Total return -2% · Per year -0%
150.12
Total return 72% · Per year 11%
What moves the 3-year price the most
  • Exit P/E± 22.38
  • Net margin± 15.67
  • Annual revenue growth± 14.15
  • Annual dilution± 1.32

AI analysis

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

In brief

Kimberly-Clark (KMB) is a global maker of essential products from fibers and nonwovens, with brands such as Huggies, Kleenex and Scott sold in more than 175 countries and territories 1. The company is preparing to acquire Kenvue, for which about 6.7 billion USD is expected to be paid 1, and completed a joint venture with Suzano for its IFP operations, valued at about 1.7 billion USD 12. The 2026 outlook shows organic sales growth slightly below its categories, due to China disruptions 3.

SWOT

Strengths

  • A brand portfolio with top market positions in many countries and strong global recognition 1.
  • Manufacturing and sales presence in a very large number of countries, with a geographically diversified portfolio 1.
  • Financial discipline and a structured program of cost savings and operational transformation 12.

Weaknesses

  • Dependence on a few large customers, especially one retail chain that accounts for a significant share of sales 1.
  • Exposure to volatile pulp, petroleum and energy prices that can affect margins 1.
  • Vulnerability to social media disruption and consumer perception in sensitive markets 23.

Opportunities

  • Integrating Kenvue could extend the portfolio into consumer health if synergies are realized 12.
  • Innovation and premiumization in core categories could support growth above category rates 1.
  • Savings from the transformation program could improve profitability if they are sustained 12.

Threats

  • Pricing pressure from private label brands and discount retailers 1.
  • Declining birth rates in several key countries could reduce baby care category volumes 1.
  • Geopolitical and trade risks, including tensions in the Middle East and the war in Ukraine, could affect costs and operations 12.

Risks

  • Raw material and energy costshigh

    Rising prices for pulp, petroleum-based materials and energy could hurt results if selling price adjustments lag 1.

  • Kenvue integrationhigh

    The value and synergies of the deal depend on financing terms and share price, and completion could be delayed or fail 13.

  • China disruptionmedium

    False product claims could continue to weigh on sales and profits in the near term 23.

  • Currency and political riskmedium

    Currency movements and exchange restrictions could affect results from operations outside the U.S. 1.

  • Cybersecuritymedium

    Cyberattacks or data breaches could disrupt operations and generate remediation costs and fines 1.

Investment thesis

What would need to be true (bull case)

  • Leading brand positions and the savings program could support margins if raw material prices stabilize 12.
  • The Kenvue acquisition, if integrated successfully, could open growth in consumer health categories 12.
  • Broad global presence could offset weakness in individual markets 1.

What would break the thesis

  • Organic growth slightly below categories, combined with China disruption, could limit profit growth in 2026 3.
  • Extra energy and raw material costs linked to Middle East conflicts could pressure margins 2.
  • Pressure from private label and large retailers could reduce prices and sales of higher-margin products 1.

What to watch

  • Final third quarter results and the evolution of the 2026 outlookQ3 2026
  • Completion of the Kenvue transaction and its financing terms2026
  • Realization of transformation savings through the end of 20282027

Products, market & competition

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

The business

Kimberly-Clark manufactures and markets a wide range of products made from natural or synthetic fibers, using technologies in fibers, nonwovens and absorbency 1. Its portfolio includes Huggies, Kleenex, Scott, Kotex and Cottonelle, which hold No. 1 or No. 2 share positions in about 70 countries 1. The company organizes its products into five daily-need categories: Baby & Child Care, Adult Care, Feminine Care, Family Care and Professional 1.

Key raw materials are kraft pulp for tissue, polypropylene and other synthetics for nonwovens, and superabsorbent materials for diapers and incontinence products 1. Price changes in these inputs and energy can affect margins if selling price adjustments trail cost increases 1. Sales are made mainly through supermarkets, mass merchandisers and drugstores 1.

In 2026 the company extended its 2024 Transformation Initiative through the end of 2028, and the Kenvue and IFP transactions signal a portfolio shift toward categories with long-term potential 12. This could change the growth profile and margins if integration proceeds as planned 23.

Segments

North America (NA)

The NA segment covers sales in the United States and Canada, where the largest customer, Walmart, accounts for a significant share of sales 1. NA operations were reorganized after the IFP transaction and are reported separately from operations outside the region 1.

International Personal Care (IPC)

The IPC segment brings together the international operations that remain after the IFP transaction, including developing markets such as China, Eastern Europe, ASEAN and Latin America 1. About half of net sales come from outside the U.S., making the segment sensitive to currency and political risks 1.

Market context

The personal care and household products market is highly competitive globally, with global, regional and local manufacturers, including private label producers selling at lower prices 1. The company notes growing concentration among large retailers, discounters and e-tailers 1.

Trends

  • Declining birth ratesheadwind

    Baby and child care sales are closely tied to birth rates, and declines in China, South Korea and the U.S. have weighed on volume growth 1. The company aims to offset this through innovation and premiumization 1.

  • China social media disruptionheadwind

    In the second quarter of 2026, false claims about the quality of certain diaper brands in China significantly affected sales, and the impact could continue in the near term 2. The company says independent testing confirmed product quality 23.

  • Middle East conflict and energy pricesheadwind

    Geopolitical tensions have raised oil and petroleum-derived raw material prices, which could add input costs in the second half of 2026 2. The company is evaluating mitigation actions 2.

  • Transformation program and savingstailwind

    The 2024 Transformation Initiative, extended through the end of 2028, targets gross productivity savings of 3.0 billion USD and a lower structural cost base 12. Most of the expected SG&A savings have already been realized or approved for action 2.

Competitive position

Kimberly-Clark faces several major competitors in most of its markets, some of which are larger and more diversified than the company 1. The main elements of competition are brand recognition, product innovation, quality, price, and marketing and distribution capabilities 1.

Competitive pressure also comes from private label, especially in Baby and Child Care and Family Care, and growing private label purchases could reduce sales of higher-margin products 1.

  • Private label manufacturers

    Lower-priced offerings in Baby and Child Care and Family Care, pressuring prices 1.

  • Global, regional and local manufacturers

    Competition on price, innovation and distribution across all of the company's markets 1.

  • Large retailers and discounters

    Increasing retail concentration with pressure on pricing 1.

  • Larger, more diversified consumer products companies

    Competitors with broader scale in several markets, relevant for brand and innovation comparison 1.

News & filings

In the press

No news in our archive over the last 180 days.

SEC filings

  • Current report04 Nov 2026
    Material agreement · Creation of a direct financial obligation · Item 3.03 · Other events · Financial statements and exhibits
  • Current report02 Nov 2026
    Acquisition or disposition of assets · Exit or disposal costs · Departure or appointment of officers · Amendments to articles or bylaws · Regulation FD disclosure · Financial statements and exhibits
  • Current report29 Oct 2026
    Material agreement · Creation of a direct financial obligation · Other events · Financial statements and exhibits
  • Current report28 Oct 2026
    Other events · Financial statements and exhibits
  • Current report20 Oct 2026
    Other events · Financial statements and exhibits
  • Current report15 Oct 2026
    Results of operations · Regulation FD disclosure · Financial statements and exhibits
  • Current report13 Oct 2026
    Other events · Financial statements and exhibits
  • Current report01 Oct 2026
    Departure or appointment of officers
  • Current report28 Sept 2026
    Other events · Financial statements and exhibits
  • Quarterly report04 Aug 2026

Sources

  1. [1] Form 10-K, fiscal year ended 2025-12-31 · SEC / Kimberly-Clark Corporation · 12 Feb 2026
  2. [2] Form 10-Q, quarter ended 2026-06-30 · SEC / Kimberly-Clark Corporation · 04 Aug 2026
  3. [3] Form 8-K, results release (exhibit 99.1) · SEC / Kimberly-Clark Corporation · 15 Oct 2026

Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.